COVID-19 Impact on Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size, Status and Forecast 2020-2026

August 2020 | 91 pages | ID: CDBF714D7593EN
QYResearch

Abstracts

This report focuses on the global Phosphoinositide 3-Kinase (PI3K) Inhibitors status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Phosphoinositide 3-Kinase (PI3K) Inhibitors development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Bayer AG
• Gilead Sciences Inc.
• Novartis AG
• TG Therapeutics Inc.
• Verastem Inc.
• ...

Market segment by Type, the product can be split into

• CLL - Chronic Iymphocytic Ieukemia
• FL - Follicular Iymphoma
• Other Indications

Market segment by Application, split into

• hospital
• Research Institutes and Research Institutions
• Clinic
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Phosphoinositide 3-Kinase (PI3K) Inhibitors status, future forecast, growth opportunity, key market and key players.
• To present the Phosphoinositide 3-Kinase (PI3K) Inhibitors development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Phosphoinositide 3-Kinase (PI3K) Inhibitors are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue
1.4 Market Analysis by Type
  1.4.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 CLL - Chronic Iymphocytic Ieukemia
  1.4.3 FL - Follicular Iymphoma
  1.4.4 Other Indications
1.5 Market by Application
  1.5.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Application: 2020 VS 2026
  1.5.2 hospital
  1.5.3 Research Institutes and Research Institutions
  1.5.4 Clinic
  1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): Phosphoinositide 3-Kinase (PI3K) Inhibitors Industry Impact
  1.6.1 How the Covid-19 is Affecting the Phosphoinositide 3-Kinase (PI3K) Inhibitors Industry
    1.6.1.1 Phosphoinositide 3-Kinase (PI3K) Inhibitors Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Phosphoinositide 3-Kinase (PI3K) Inhibitors Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Phosphoinositide 3-Kinase (PI3K) Inhibitors Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Perspective (2015-2026)
2.2 Phosphoinositide 3-Kinase (PI3K) Inhibitors Growth Trends by Regions
  2.2.1 Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Phosphoinositide 3-Kinase (PI3K) Inhibitors Historic Market Share by Regions (2015-2020)
  2.2.3 Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Growth Strategy
  2.3.6 Primary Interviews with Key Phosphoinositide 3-Kinase (PI3K) Inhibitors Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Phosphoinositide 3-Kinase (PI3K) Inhibitors Players by Market Size
  3.1.1 Global Top Phosphoinositide 3-Kinase (PI3K) Inhibitors Players by Revenue (2015-2020)
  3.1.2 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Market Share by Players (2015-2020)
  3.1.3 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Concentration Ratio
  3.2.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue in 2019
3.3 Phosphoinositide 3-Kinase (PI3K) Inhibitors Key Players Head office and Area Served
3.4 Key Players Phosphoinositide 3-Kinase (PI3K) Inhibitors Product Solution and Service
3.5 Date of Enter into Phosphoinositide 3-Kinase (PI3K) Inhibitors Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Historic Market Size by Type (2015-2020)
4.2 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecasted Market Size by Type (2021-2026)

5 PHOSPHOINOSITIDE 3-KINASE (PI3K) INHIBITORS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2015-2020)
5.2 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2015-2020)
6.2 Phosphoinositide 3-Kinase (PI3K) Inhibitors Key Players in North America (2019-2020)
6.3 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2015-2020)
6.4 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2015-2020)
7.2 Phosphoinositide 3-Kinase (PI3K) Inhibitors Key Players in Europe (2019-2020)
7.3 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2015-2020)
7.4 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2015-2020)

8 CHINA

8.1 China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2015-2020)
8.2 Phosphoinositide 3-Kinase (PI3K) Inhibitors Key Players in China (2019-2020)
8.3 China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2015-2020)
8.4 China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2015-2020)
9.2 Phosphoinositide 3-Kinase (PI3K) Inhibitors Key Players in Japan (2019-2020)
9.3 Japan Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2015-2020)
9.4 Japan Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2015-2020)
10.2 Phosphoinositide 3-Kinase (PI3K) Inhibitors Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2015-2020)
10.4 Southeast Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2015-2020)

11 INDIA

11.1 India Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2015-2020)
11.2 Phosphoinositide 3-Kinase (PI3K) Inhibitors Key Players in India (2019-2020)
11.3 India Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2015-2020)
11.4 India Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2015-2020)
12.2 Phosphoinositide 3-Kinase (PI3K) Inhibitors Key Players in Central & South America (2019-2020)
12.3 Central & South America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2015-2020)
12.4 Central & South America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Bayer AG
  13.1.1 Bayer AG Company Details
  13.1.2 Bayer AG Business Overview and Its Total Revenue
  13.1.3 Bayer AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Introduction
  13.1.4 Bayer AG Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2015-2020))
  13.1.5 Bayer AG Recent Development
13.2 Gilead Sciences Inc.
  13.2.1 Gilead Sciences Inc. Company Details
  13.2.2 Gilead Sciences Inc. Business Overview and Its Total Revenue
  13.2.3 Gilead Sciences Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Introduction
  13.2.4 Gilead Sciences Inc. Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2015-2020)
  13.2.5 Gilead Sciences Inc. Recent Development
13.3 Novartis AG
  13.3.1 Novartis AG Company Details
  13.3.2 Novartis AG Business Overview and Its Total Revenue
  13.3.3 Novartis AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Introduction
  13.3.4 Novartis AG Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2015-2020)
  13.3.5 Novartis AG Recent Development
13.4 TG Therapeutics Inc.
  13.4.1 TG Therapeutics Inc. Company Details
  13.4.2 TG Therapeutics Inc. Business Overview and Its Total Revenue
  13.4.3 TG Therapeutics Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Introduction
  13.4.4 TG Therapeutics Inc. Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2015-2020)
  13.4.5 TG Therapeutics Inc. Recent Development
13.5 Verastem Inc.
  13.5.1 Verastem Inc. Company Details
  13.5.2 Verastem Inc. Business Overview and Its Total Revenue
  13.5.3 Verastem Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Introduction
  13.5.4 Verastem Inc. Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2015-2020)
  13.5.5 Verastem Inc. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Phosphoinositide 3-Kinase (PI3K) Inhibitors Key Market Segments
Table 2. Key Players Covered: Ranking by Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue
Table 3. Ranking of Global Top Phosphoinositide 3-Kinase (PI3K) Inhibitors Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of CLL - Chronic Iymphocytic Ieukemia
Table 6. Key Players of FL - Follicular Iymphoma
Table 7. Key Players of Other Indications
Table 8. COVID-19 Impact Global Market: (Four Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Phosphoinositide 3-Kinase (PI3K) Inhibitors Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Phosphoinositide 3-Kinase (PI3K) Inhibitors Players to Combat Covid-19 Impact
Table 13. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Regions (2015-2020)
Table 17. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Growth Strategy
Table 23. Main Points Interviewed from Key Phosphoinositide 3-Kinase (PI3K) Inhibitors Players
Table 24. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue by Players (2015-2020) (Million US$)
Table 25. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Players (2015-2020)
Table 26. Global Top Phosphoinositide 3-Kinase (PI3K) Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors as of 2019)
Table 27. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Phosphoinositide 3-Kinase (PI3K) Inhibitors Product Solution and Service
Table 30. Date of Enter into Phosphoinositide 3-Kinase (PI3K) Inhibitors Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 33. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Share by Type (2015-2020)
Table 34. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Market Share by Type (2021-2026)
Table 35. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Share by Application (2015-2020)
Table 36. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 37. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Share by Application (2021-2026)
Table 38. North America Key Players Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share (2019-2020)
Table 40. North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 41. North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Type (2015-2020)
Table 42. North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 43. North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Application (2015-2020)
Table 44. Europe Key Players Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share (2019-2020)
Table 46. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Type (2015-2020)
Table 48. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Application (2015-2020)
Table 50. China Key Players Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue (2019-2020) (Million US$)
Table 51. China Key Players Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share (2019-2020)
Table 52. China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 53. China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Type (2015-2020)
Table 54. China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 55. China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Application (2015-2020)
Table 56. Japan Key Players Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share (2019-2020)
Table 58. Japan Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Type (2015-2020)
Table 60. Japan Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share (2019-2020)
Table 64. Southeast Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Type (2015-2020)
Table 66. Southeast Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Application (2015-2020)
Table 68. India Key Players Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue (2019-2020) (Million US$)
Table 69. India Key Players Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share (2019-2020)
Table 70. India Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 71. India Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Type (2015-2020)
Table 72. India Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 73. India Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share (2019-2020)
Table 76. Central & South America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Type (2015-2020)
Table 78. Central & South America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Application (2015-2020)
Table 80. Bayer AG Company Details
Table 81. Bayer AG Business Overview
Table 82. Bayer AG Product
Table 83. Bayer AG Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2015-2020) (Million US$)
Table 84. Bayer AG Recent Development
Table 85. Gilead Sciences Inc. Company Details
Table 86. Gilead Sciences Inc. Business Overview
Table 87. Gilead Sciences Inc. Product
Table 88. Gilead Sciences Inc. Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2015-2020) (Million US$)
Table 89. Gilead Sciences Inc. Recent Development
Table 90. Novartis AG Company Details
Table 91. Novartis AG Business Overview
Table 92. Novartis AG Product
Table 93. Novartis AG Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2015-2020) (Million US$)
Table 94. Novartis AG Recent Development
Table 95. TG Therapeutics Inc. Company Details
Table 96. TG Therapeutics Inc. Business Overview
Table 97. TG Therapeutics Inc. Product
Table 98. TG Therapeutics Inc. Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2015-2020) (Million US$)
Table 99. TG Therapeutics Inc. Recent Development
Table 100. Verastem Inc. Company Details
Table 101. Verastem Inc. Business Overview
Table 102. Verastem Inc. Product
Table 103. Verastem Inc. Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2015-2020) (Million US$)
Table 104. Verastem Inc. Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Type: 2020 VS 2026
Figure 2. CLL - Chronic Iymphocytic Ieukemia Features
Figure 3. FL - Follicular Iymphoma Features
Figure 4. Other Indications Features
Figure 5. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Application: 2020 VS 2026
Figure 6. hospital Case Studies
Figure 7. Research Institutes and Research Institutions Case Studies
Figure 8. Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Phosphoinositide 3-Kinase (PI3K) Inhibitors Report Years Considered
Figure 11. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Regions: 2020 VS 2026
Figure 13. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Players in 2019
Figure 16. Global Top Phosphoinositide 3-Kinase (PI3K) Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue in 2019
Figure 18. North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bayer AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Bayer AG Revenue Growth Rate in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2015-2020)
Figure 27. Gilead Sciences Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Gilead Sciences Inc. Revenue Growth Rate in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2015-2020)
Figure 29. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Novartis AG Revenue Growth Rate in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2015-2020)
Figure 31. TG Therapeutics Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. TG Therapeutics Inc. Revenue Growth Rate in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2015-2020)
Figure 33. Verastem Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Verastem Inc. Revenue Growth Rate in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2015-2020)
Figure 35. Bottom-up and Top-down Approaches for This Report
Figure 36. Data Triangulation
Figure 37. Key Executives Interviewed